Filtered By:
Condition: Heart Disease
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1253 results found since Jan 2013.
Two New Reports From eHealth Initiative Provide Valuable Information On eHealth Tools For Cancer Patients
Since we have started the conversation about eHealth tools in my previous blog this week, I thought it might be worthwhile to explore some of the other applications and internet based programs that may be useful to cancer patients.
As I wrote in early February, I have become (and remain) infatuated with apps that have helped me track my activity and my diet. They have made a big difference for me and others I know, and continue to keep me motivated and on target. The larger question, however, is whether we can harness electronic media to help us live healthier lives, get better control of our health, or if we have an illne...
Source: Dr. Len's Cancer Blog - March 8, 2013 Category: Cancer Authors: Dr. Len Tags: Access to care Cancer Care Media Survivors Treatment Source Type: blogs
If Breast Cancer Doesn ' t Kill You, Heart Failure Might
File this in the category of the stuff we should have been told but weren ' t. Many women diagnosed with breast cancer, are given chemotherapy as part of their treatment. One of the drugs commonly used is calledDoxorubicin, also known Adriamycin or Rubex, or as us patients have been known to call it ' red devil ' , which carries a significant cardiac risk.When you are given it in chemo the nurses put on masks and special gowns to protect them. No thought of the patients. I was told it could cause some cardiac issues but now I am learning that the danger is very real and very concerning." “Both breast cancer and cardiovas...
Source: Caroline's Breast Cancer Blog - February 2, 2018 Category: Cancer & Oncology Tags: breast cancer treatment cardiac chemotherapy Source Type: blogs
Cancer and the Latino Community: Lessons Learned
I had the privilege this week to serve as the keynote speaker for the 4th Summit sponsored by Latinas Contra Cancer-an organization founded and led by Ysabel Duron, a formidable cancer survivor and news media presence in San Francisco.
Bringing together members of the Latino community, researchers, community health workers, promotores (more on that later) and advocates, the summit focused on the issues facing the Latino community in increasing awareness, access to care, improved treatment and research opportunities among other topics. But what was most impressive was the spirit, engagement and commitment that permeated the...
Source: Dr. Len's Cancer Blog - July 24, 2014 Category: Cancer Authors: Dr. Len Tags: Access to care Breast Cancer Cancer Care Cervical Cancer Colon Cancer Diet Early detection Environment Prevention Prostate Cancer Research Screening Tobacco Source Type: blogs
Normal Care Hours Don’t Work for Workers With Chronic Conditions
It looks like an airport lounge without the rolling suitcases. There are about 20 of us cancer survivor-types fiddling with our phones or reading the newspaper. A few of us are sipping delicious contrast fluid in preparation for a scan, but most of us are waiting to meet with our oncologists for follow-up or monitoring visits. All of us are between the ages of 20 and 70 and all of us are dressed for success – or at least for our jobs.
What’s wrong with this picture? Why are employed adults spending a busy Wednesday morning waiting (and waiting) to visit our oncologists when we should be working?
We are there becaus...
Source: Disruptive Women in Health Care - February 13, 2014 Category: Health Medicine and Bioethics Commentators Authors: dw at disruptivewomen.net Tags: Cancer Chronic Conditions Patients Source Type: blogs
Cancer Survivors Exhibit a Significantly Higher Risk of Cardiovascular Disease
The dominant cancer therapies of chemotherapy and radiotherapy have not yet been replaced by immunotherapies for more than a handful of cancer types. These classes of therapy produce a significantly increased burden of senescent cells in patients; one of the goals of cancer therapy is to drive cancerous cells into senescence, those that cannot be killed. These additional senescent cells in turn accelerate the progression of degenerative aging. The advent of senolytic therapies to clear senescent cells from aged tissues will make a sizable difference to these patients. More effort should be undertaken today to enable patien...
Source: Fight Aging! - July 4, 2022 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Reconceptualizing Health and Health Care: Why Our Cancer Care Delivery System Is In Crisis
Cancer Care System in Crisis
Americans fear cancer. In a poll for MetLife, when participants were asked which major disease they feared most, 41 percent said cancer, 31 percent said Alzheimer’s disease, and small percentages of other respondents said other diseases. Not surprisingly, The National Institutes of Health has a budget allocation of $4.9 billion for 2014 to The National Cancer Institute, far more than any other Institute and over 25 percent of the NIH’s total funding to study organ-based diseases ($19.2 billion).
Despite this longstanding commitment to cancer research, the Institute of Medicine (IOM) reporte...
Source: Health Affairs Blog - September 23, 2014 Category: Health Management Authors: Carolyn Payne and William Dale Tags: All Categories Chronic Care End-of-Life Care Health Care Costs Health Care Delivery Long-Term Care Source Type: blogs
Past Progress Towards Control of Cancer Has Been Slow, Steady, and Incremental
Mortality rates for cancer have diminished slowly and steadily over the past few decades. This is a matter of prevention on the one hand and improvements in early detection of cancer on the other. When caught early enough, even comparatively crude approaches to therapy have a decent chance of controlling and eliminating the cancer. This trend will no doubt continue, but the more rapid, more effective progress that we'd like to see will only emerge given the advent of universal cancer therapies, those that strike at mechanisms, such as telomere lengthening, that are shared by many or all cancers. That is a plausible goal fo...
Source: Fight Aging! - January 23, 2019 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
National Minority Health Month Is A Call To Action
April is National Minority Health Month.
That's the "dry" statement. The impact statement is that-unfortunately-for many in this country, this is more than a phrase. It's a reality that their health and their health care are in crisis. And the sooner more of us understand this, the sooner we can make a genuine effort to implement effective strategies that will address the sad state of affairs many people find themselves in when it comes to their health, and preventing and appropriately treating their diseases.
This is about more than high blood pressure and diabetes. It's about heart disease and stroke and cancer and the l...
Source: Dr. Len's Cancer Blog - April 18, 2013 Category: Cancer Authors: Dr. Len Tags: Access to care Breast Cancer Cancer Care Cervical Cancer Colon Cancer Early detection Environment Prevention Screening Survivors Treatment Source Type: blogs
Mortality Versus Survival In International Comparisons Of Cancer Care
In a recent paper, Soneji and Yang revisit a topic we first explored in the April 2012 issue of Health Affairs — namely, whether the U.S. gets value for its cancer care. We found that life expectancy after cancer diagnosis rose more quickly for patients in the U.S. than for patients in Europe. Moreover, while spending per patient also rose more quickly in the U.S., Americans still received good value from the health care system. Compared to the gains seen in Europe, for example, each additional life-year gained in the U.S. cost roughly $20,000 in additional U.S. spending.
Soneji and Yang re-examine trends in cancer d...
Source: Health Affairs Blog - March 20, 2015 Category: Health Management Authors: Dana Goldman, Darius Lakdawalla, and Tomas Philipson Tags: All Categories Business of Health Care Comparative Effectiveness Consumers Europe Health Care Costs Health Care Delivery Prevention Public Health Research Source Type: blogs
Onco-cardiology, or Cardio-oncology
I was at a Cardiology Education Meeting where a case was presented of a patient receiving a monoclonal antibody for melanoma, who may have then developed myocarditis.Onco-cardiology (or cardio-oncology) is the study of the cardiac effects of cancer treatment but also used to refer to patients who are cancer survivors with a cardiac condition or people living with both conditions.Though not a new term, I don ' t remember coming across it before. Here is some introductory reading:Some recent freely available articles (with links to PubMed):Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatme...
Source: Browsing - July 3, 2017 Category: Databases & Libraries Tags: cancer cardiology Source Type: blogs
Removing the Fallopian Tubes to Prevent Ovarian Cancer – Something to Consider
New information strongly suggests that most ovarian cancers originate, not in the ovary, but in the fallopian tube. If this is so, then removal of the fallopian tubes may actually prevent ovarian cancer.
The evidence is powerful enough that the American Congress of Obstetricians & Gynecologists is now recommending that fallopian tube removal be considered in women planning to undergo surgical sterilization or hysterectomy.
The Fallopian Tube Origin of Ovarian Cancer
We used to think that ovarian cancer originated in the peritoneal lining that covers the ovaries and abdominal organs. But the fallopian tube origin of ova...
Source: The Blog That Ate Manhattan - January 23, 2015 Category: Primary Care Authors: Margaret Polaneczky, MD Tags: Best of TBTAM Family Planning Ovarian Cancer Essure Fallopian tube oophorectomy prophylactic salpingectomy Sterilization Tie my tuibes tubal ligation Tubes Source Type: blogs
Aspirin and breast cancer risk: How a wonder drug may become more wonderful
Aspirin has been called a wonder drug. And it’s easy to see why.
It’s inexpensive, its side effects are well-known and generally minor. And since it was developed in the 1890s, it’s been shown to provide a number of potential benefits, such as relieving pain, bringing down a fever, and preventing heart attacks and strokes. Over the last 20 years or so, the list of aspirin’s potential benefits has been growing. And it might be about to get even longer: did you know that aspirin may lower your risk of several types of cancer?
Studies of aspirin and cancer
A number of studies suggest that aspirin can lower the risk of...
Source: Harvard Health Blog - October 23, 2020 Category: Consumer Health News Authors: Robert H. Shmerling, MD Tags: Breast Cancer Health Source Type: blogs
Do Most Breast Cancer Patients Develop PTSD?
I’m grateful to Traci Pedersen for her March 3, 2016 article “Study Finds Most Breast Cancer Patients Develop PTSD Symptoms,” and to Dr. Grohol for all his efforts to help people heal from trauma.
I’d say 99% of breast cancer patients develop PTSD, even though symptoms may be repressed. It would require a remarkable childhood not to do so.
First, breast cancer is an immediate life threat. At diagnosis, the brain sets off our fight-flight stress chemicals, then for a minimum of a year or more (the suspense often lasts much longer), it’s like having a gun held to your head 24 x 7.
If someone did hold ...
Source: World of Psychology - April 20, 2017 Category: Psychiatry & Psychology Authors: Kathy Brous Tags: Health-related Mental Health and Wellness Research Trauma Women's Issues Attachment Breast Cancer Negativity Bias Oncology Posttraumatic Stress Disorder Psychological Trauma Traumatic Events Source Type: blogs
Long-term statin use protects against prostate cancer death
Statins and other drugs that lessen cardiovascular disease risk by lowering blood lipids rank among the world’s most prescribed medications. And for the men who take them, accumulating evidence has for years pointed to another added benefit: a lower risk of developing prostate cancer.
Now researchers are reporting that long-term statin use (more than 10 years) can also reduce the odds of a prostate cancer death. The new findings come from a study led by Alison Mondul, a cancer epidemiologist at the University of Michigan School of Public Health.
Mondul says that most men develop slow-growing, indolent prostate cancers th...
Source: Harvard Health Blog - January 7, 2019 Category: Consumer Health News Authors: Charlie Schmidt Tags: Living With Prostate Cancer Prostate Knowledge HPK Source Type: blogs
Heart disease and breast cancer: Can women cut risk for both?
Very often I encounter women who are far more worried about breast cancer than they are about heart disease. But women have a greater risk of dying from heart disease than from all cancers combined. This is true for women of all races and ethnicities. Yet only about 50% of women realize that they are at greater risk from heart disease than from anything else.
Currently in the US, three million women are living with breast cancer, which causes one in 31 deaths. Almost 50 million women have cardiovascular disease, which encompasses heart disease and strokes and causes one in three deaths.
Here’s what’s really interestin...
Source: Harvard Health Blog - January 8, 2019 Category: Consumer Health News Authors: Monique Tello, MD, MPH Tags: Breast Cancer Exercise and Fitness Health Healthy Eating Heart Health Women's Health Source Type: blogs
